Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 273

Similar articles for PubMed (Select 9935129)

3.
4.

Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.

Raudaskoski TH, Lahti EI, Kauppila AJ, Apaja-Sarkkinen MA, Laatikainen TJ.

Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):114-9.

PMID:
7847516
5.

Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response.

Raudaskoski T, Tapanainen J, Tomás E, Luotola H, Pekonen F, Ronni-Sivula H, Timonen H, Riphagen F, Laatikainen T.

BJOG. 2002 Feb;109(2):136-44.

PMID:
11888095
6.

Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.

Ross AH, Boyd ME, Colgan TJ, Ferenczy A, Fugere P, Lorrain J.

Obstet Gynecol. 1993 Nov;82(5):773-9.

PMID:
8414325
7.

A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.

Christodoulakos GE, Botsis DS, Lambrinoudaki IV, Papagianni VD, Panoulis CP, Creatsa MG, Alexandrou AP, Augoulea AD, Dendrinos SG, Creatsas GC.

Maturitas. 2006 Mar 20;53(4):413-23. Epub 2005 Sep 2.

PMID:
16140483
8.

Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.

Boerrigter PJ, van de Weijer PH, Baak JP, Fox H, Haspels AA, Kenemans P.

Maturitas. 1996 May;24(1-2):63-71.

PMID:
8794436
9.

Continuous low-dose oestrogen and progestogen hormone replacement therapy: a randomised trial.

MacLennan AH, MacLennan A, Wenzel S, Chambers HM, Eckert K.

Med J Aust. 1993 Jul 19;159(2):102-6.

PMID:
8336583
11.

Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women.

Cameron ST, Critchley HO, Glasier AF, Williams AR, Baird DT.

Br J Obstet Gynaecol. 1997 Oct;104(10):1184-90.

PMID:
9332998
12.
13.

Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.

Yildirim G, Tugrul S, Uslu H, Pekin O, Eren S.

Arch Gynecol Obstet. 2006 Feb;273(5):268-73. Epub 2005 Nov 29.

PMID:
16315025
14.

A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.

Hilditch JR, Lewis J, Ross AH, Peter A, van Maris B, Franssen E, Charles J, Norton P, Dunn EV.

Maturitas. 1996 Jul;24(3):177-84.

PMID:
8844631
16.

Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study Group.

Nand SL, Webster MA, Baber R, O'Connor V.

Obstet Gynecol. 1998 May;91(5 Pt 1):678-84.

PMID:
9572210
17.

A comparative study of two levonorgestrel-containing hormone replacement therapy regimens of efficacy and tolerability variables.

Gräser T, Rössner P, Schubert K, Müller A, Bönisch U, Oettel M.

Maturitas. 1997 Dec 15;28(2):169-79.

PMID:
9522325
20.

Estrogen and interrupted progestin: a new concept for menopausal hormone replacement therapy.

Casper RF, Chapdelaine A.

Am J Obstet Gynecol. 1993 Apr;168(4):1188-94; discussion 1194-6.

PMID:
8475965
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk